We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Wants Updated Warnings for Some Antidepressants
FDA Wants Updated Warnings for Some Antidepressants
February 6, 2009
The FDA is requiring manufacturers of two types of antidepressants, selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRI), to update their drug warnings with information on neuroleptic malignant syndrome (NMS).